Artigos da tag: prostate cancer research

Christine Galustian has been awarded a grant to investigate whether loss of a particular protein increases the risk of prostate cancer in African-Caribbean men. More about our researchers: https://prostatecanceruk.org/research/our-researchers She has also received a grant to support her work looking at how white blood cells interact with cancer; an approach that could help the immune system...
Professor Craig Robson's lab is interested in the molecular biology, otherwise known as the nuts and bolts, of prostate cancer. More about our researchers: http://prostatecanceruk.org/research/our-researchers His lab members hold four Prostate Cancer UK grants between them, each covering a different stage of a scientist's career, from PhD student (James) to established scientist (Craig), via newly independent...
More about our researchers: http://prostatecanceruk.org/research/our-researchers Prostate Cancer UK PhD studentships are awarded to train the next generation of prostate cancer researchers. Mario de Piano is a PhD student in Claire Wells' lab, tackling how and why cancer cells spread -- and whether they use fat as an energy source.
Night urination is determined as waking up once or more throughout the night to be able to urinate.  This might be a common phenomenon that affects the quality of lifetime of much of the population and may have an effect on the average number of years a person can expect to live . It arises resulting from quite a...
NanoKnife is a device which implements technology called irreversible electroporation to electrically target and kill specific tumor cells. The "NanoKnife" is actually an electric field – that can be precisely targeted to "poke" tiny holes in tumor cells, while not affecting adjacent organs. The ultra-precision of the NanoKnife allows physicians to treat tumors that in the past would have...
swollen prostate treatment is hard to find just as hard as having the problem. But you didn't know that there are new prostate treatment options around the market waiting for you to pick them up. You're one of those people who seek treatment, right? It is because you got yourself into this page. Let's discuss prostate problems and...
Scientists in the US led by Dr. Mark Greene of the University of Pennsylvania School of Medicine have developed a monoclonal antibody that they hope will become a successful therapeutic agent against prostate cancer. Every year thousands of men die from aggressive forms of this disease. This research holds out hope for those affected although it will be some...
Prostate cancer survival rates indicate the chances a cancer patient has of surviving the disease for a specified length of time. The rates are by no means that a certain indicator of what will happen to a patient; they'll at best predict a patient's probabilities of what may happen to him, if a type of treatment plan is opted...
Prostate cancer is very common in males. If detected in early stages, it is fully curable. Chemotherapy and radiation therapies are the most common treatments. But some times due to the detection in later stages and its spread to nearby organs it is very difficult to control it or eradicate it by surgery. At this age even medicines are...
The prostate is a sex gland that is only in men. An alternative treatment for prostate cancer is necessary because the conventional treatments actually cause cancer to return. By conventional treatments I'm talking of course about radiation therapy and chemotherapy. Both cause severe damage to the immune system. We need a healthy immune system to keep prostate cancer from...